Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001609351-16-000013
Filing Date
2016-01-08
Accepted
2016-01-08 16:05:13
Documents
1
Period of Report
2016-01-06

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_145228710238226.html 4  
1 FORM 4 wf-form4_145228710238226.xml 4 3887
  Complete submission text file 0001609351-16-000013.txt   5347
Mailing Address 334 CR 692 BUFFALO GAP TX 79508
Business Address
Zoth Lota S. (Reporting) CIK: 0001278219 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36819 | Film No.: 161333259

Mailing Address 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104
Business Address 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104 888-772-7560
Spark Therapeutics, Inc. (Issuer) CIK: 0001609351 (see all company filings)

EIN.: 462654405 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)